辅助生殖技术治疗费用分担机制研究  

Study on the Cost Sharing Mechanism of Assisted Reproductive Technology Treatment

作　　者：郑思越 李欣雨 廖云鹏 徐娟[1,2] ZHENG Siyue;LI Xinyu;LIAO Yunpeng;XU Juan(School of Medicine and Health Management,Tongji Medical College,Huazhong University of Science and Technology,Wuhan Hubei 430030,China;不详)

机构地区：[1]华中科技大学同济医学院医药卫生管理学院,湖北武汉430030 [2]华中科技大学文科双一流建设重大学科平台(医院高质量发展研究中心),湖北武汉430030

出　　处：《卫生经济研究》2024年第11期62-66,70,共6页

基　　金：2021—2022年华中科技大学文科处立项“不孕不育防治和辅助生殖技术应用现状的国内外研究”(H20220016)。

摘　　要：当前,辅助生殖技术治疗需求不断增加,但在我国目前的多层次医疗保障体系下,尚未形成辅助生殖技术治疗费用分担机制。可借鉴德国、澳大利亚、日本辅助生殖技术治疗费用分担的实践经验:破除政策障碍,为辅助生殖技术费用保障提供合规性支持;强化政府责任,完善建立多元主体的费用共担机制;拓宽筹资渠道,形成稳定的资金来源;明确资金使用条件,控制医疗费用支出水平;采用综合控费手段,减轻患者自付费用负担。At present,the demand for assisted reproductive technology treatment is increasing.However,under current multi-level medical insurance system in China,the cost sharing mechanism for assisted reproductive technology treatment has not yet been formed.Learned from the practical experiences of Germany,Australia and Japan in sharing the cost of assisted reproductive technology treatment,it is necessary to break down the policy barriers and provide compliance support for assisted reproductive technology cost protection,strengthen the responsibility of the government and improve the establishment of the cost sharing mechanism of multiple main bodies,broaden the financing channels to form a stable source of funds,clarify the conditions for the use of funds and control the level of medical expenses,and adopt comprehensive cost control measures to reduce the burden of out-of-pocket expenses on patients.

关 键 词：辅助生殖技术 治疗费用 分担机制 

分 类 号：R19[医药卫生—卫生事业管理]